Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bill introduced to repeal competitive bidding program

This article was originally published in The Gray Sheet

Executive Summary

H.R. 3790 is introduced Oct. 13 in the House by Rep. Kendrick Meek, D-Fla., and 34 cosponsors to end Medicare's controversial competitive bidding program for durable medical equipment, prosthetics, orthotics and supplies (DMEPOS). The bill would halt a bidding process that began in nine metropolitan areas on Oct. 21. CMS says the competitive bidding program would save Medicare up to $1 billion annually once fully implemented, but the American Association for Homecare, which represents equipment makers and home health care providers, argues that the bidding program will drive DMEPOS retailers out of business and ultimately reduce patient access to care (1"The Gray Sheet" Aug. 17, 2009). A lobbying drive by DMEPOS manufacturers and home health care advocates in 2008 moved Congress to make changes and delay the implementation date (2"The Gray Sheet" July 14, 2008)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028071

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel